HomeCompareTMOAY vs MRK

TMOAY vs MRK: Dividend Comparison 2026

TMOAY yields 74.07% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TMOAY wins by $1.21M in total portfolio value
10 years
TMOAY
TMOAY
● Live price
74.07%
Share price
$2.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.27M
Annual income
$347,213.33
Full TMOAY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TMOAY vs MRK

📍 TMOAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTMOAYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TMOAY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TMOAY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TMOAY
Annual income on $10K today (after 15% tax)
$6,296.30/yr
After 10yr DRIP, annual income (after tax)
$295,131.33/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TMOAY beats the other by $286,802.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TMOAY + MRK for your $10,000?

TMOAY: 50%MRK: 50%
100% MRK50/50100% TMOAY
Portfolio after 10yr
$663.0K
Annual income
$178,505.73/yr
Blended yield
26.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TMOAY
No analyst data
Altman Z
2.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TMOAY buys
0
MRK buys
0
No recent congressional trades found for TMOAY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTMOAYMRK
Forward yield74.07%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.27M$56.8K
Annual income after 10y$347,213.33$9,798.13
Total dividends collected$1.09M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TMOAY vs MRK ($10,000, DRIP)

YearTMOAY PortfolioTMOAY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$18,107$7,407.41$11,206$366.19+$6.9KTMOAY
2$31,910$12,535.42$12,650$502.35+$19.3KTMOAY
3$54,790$20,645.72$14,407$694.19+$40.4KTMOAY
4$91,755$33,129.47$16,585$967.82+$75.2KTMOAY
5$150,029$51,851.19$19,342$1,363.89+$130.7KTMOAY
6$239,766$79,235.77$22,913$1,947.19+$216.9KTMOAY
7$374,895$118,345.50$27,662$2,823.89+$347.2KTMOAY
8$574,076$172,937.82$34,159$4,173.35+$539.9KTMOAY
9$861,756$247,494.40$43,337$6,308.80+$818.4KTMOAY
10$1,269,292$347,213.33$56,776$9,798.13+$1.21MTMOAY

TMOAY vs MRK: Complete Analysis 2026

TMOAYStock

TomTom N.V. develops and sells navigation and location-based products and services worldwide. The company operates in two segments, Location Technology and Consumer. It offers standard definition, advanced driver assistance system (ADAS), high definition (HD) maps, and map data, as well as places for map products; traffic and travel information products, including real-time traffic, hazard warning, speed camera, speed profile, road analytics, fuel and weather services, electric vehicle (EV) and parking services, and routing; and navigation products, such as navigation engine, traffic and travel information, navigation user interface, EV routing and range, and maps for automotive. The company also provides AutoStream, a solution that enables fast and efficient map delivery of the TomTom automated driving (AD) and ADAS Maps; RoadCheck, a tool for carmakers to determine when, where, and under what conditions their vehicles can safely activate AD functions; TomTom indigo, a digital cockpit platform; and virtual horizon products. In addition, it offers road analytics solutions, including traffic stats, origin destination analysis, route monitoring, road event reporter, and junction analytics; and shop products, such as navigation devices, accessories, and map updates, as well as support services. The company serves the automotive, fleet management and logistics, mobility and on-demand, road traffic management, and location intelligence industries. TomTom N.V. was founded in 1991 and is headquartered in Amsterdam, the Netherlands.

Full TMOAY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TMOAY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TMOAY vs SCHDTMOAY vs JEPITMOAY vs OTMOAY vs KOTMOAY vs MAINTMOAY vs JNJTMOAY vs ABBVTMOAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.